Janux Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

13.76 +0.04 (+0.29%) USD | NASDAQ | Jan 16, 16:00

13.76 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Ionis Pharmaceuticals, Inc.	--
MannKind Corp.	--
Madrigal Pharmaceuticals, Inc.	--
Editas Medicine, Inc.	--